65
Mora, A., Rosa, A., Fuentes, J.M., Soler, G., Centeno, F., 1999. Different
mechanisms of protection against by valproate and of lithium. European Journal of
Biochemistry 266, 886–891.
Mora, A., Sabio, G., Soler, G., Centeno, F., 2002. Different dependence of lithium
and valproate on PI3K/PKB pathway. Bipolar Disorder 4, 195–200.
Migliore, L., Fontana, I., Colognato, R., Coppede, F., Siciliano, G., Murri, L., 2005.
Searching for the role and the most suitable biomarkers of oxidative stress in
Alzheimer's disease and in other neurodegenerative diseases. Neurobiology of
Aging 26, 587-595.
Murray, C.J., Lopez, A.D., 1997. The utility of DALYs for public health policy and
research: a reply. Bulletin World Health Organization 75(4), 377-381.
Psimadas, D., Messini-Nikolaki, N., Zafiropoulou, M., Fortos, A., Tsilimigaki, S.,
Piperakis, S.M., 2004. DNA damage and repair efficiency in lymphocytes from
schizophrenic patients. Cancer Letters 204(1), 33-40.
Ranjekar, P.K., Hinge, A., Hegde, M.V., Ghate, M., Kale, A., Sitasawad, S., Wagh,
U.V., Debsikdar, V.B., Mahadik, S.P., 2003. Decreased antioxidant enzymes and
membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood
disorder patients. Psychiatry Research 121, 109-122.